Search Results < General Internal Medicine

13 results

News
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
27 Oct 2023
News
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
Many Ukrainian refugees fleeing the war have encountered obstacles when seeking therapies for opioid use disorder in European Union countries, a new Yale-led study finds. The study examines the barriers to opioid agonist therapies (OAT) and providers’ responses to increased demand in OAT enrollment.
21 Jul 2023
News
Discoveries & Impact (November 2022)
Discoveries & Impact highlights select scientific discoveries per section across the Department of Internal Medicine...
16 Nov 2022
News
Patients Receiving Methadone Treatment Prefer Clinicians Use Medically Accurate and Destigmatizing Language
A new study by researchers at Yale School of Medicine, University of the South, Brigham and Women’s Hospital, and Quinnipiac School of Medicine found that patients receiving methadone treatment prefer that clinicians use medically accurate and person-centered terminology. The study was published in Journal of General Internal Medicine.
10 Oct 2022
News
Discoveries & Impact (May 2022)
Discoveries & Impact (May 2022)
12 May 2022
News
Yale Study Examines Relationship Among Housing Status, Patient Characteristics, and Retention Among Individuals Enrolled in Methadone Maintenance Treatment
Marina Gaeta, a Yale School of Medicine student, and Declan Barry, PhD, associate professor of psychiatry, are first and senior authors, respectively of a study in Journal of Substance Abuse Treatment that found that although low-barrier methadone clinics are able to attract and retain patients experiencing homelessness into long-term treatment, patients experiencing homelessness enrolling in low-barrier methadone face higher rates of psychiatric distress, social isolation, trauma, and chronic pain.
Source: Journal of Substance Abuse Treatment
22 Mar 2022
News
Needs of patients with opioid use disorder similar to other patients
With the magnitude of the opioid crisis, there has been a growing call for treatment of patients with opioid use disorder to be expanded beyond specialist care and into the hands of primary care physicians.
Source: YaleNews
15 Dec 2021
News
Program aims to develop creative solutions for opioid, HIV health care
Program aims to develop creative solutions for opioid, HIV health care
23 Feb 2020
News
Yale study urges life-saving drug treatment to combat Ukraine’s HIV epidemic
Yale study urges life-saving drug treatment to combat Ukraine’s HIV epidemic
1 Jan 2020
News
Yale study evaluates use of cognitive-behavioral therapy to treat opioid use disorder and chronic pain
A study by Yale researchers led by Declan Barry, PhD, Associate Professor of Psychiatry and Child Study, developed an integrated treatment approach combining psychotherapy with medication-assisted treatment.
1 Jan 2019
News
A Call to Action: Addressing America’s Drug Epidemic
The drug poisonings of more than 100 people with “K2”-branded synthetic cannabinoids (often called synthetic marijuana) around New Haven this week is a troubling example of our nation’s inadequate response to a volatile crisis.
17 Aug 2018
News
Yale study: Training addiction counselors to deliver a brief psychoeducational intervention for chronic pain among patients in opioid treatment
Declan Barry, PhD, Associate Professor of Psychiatry and Director of Pain Treatment Services at the APT Foundation, is the senior author of a paper that investigates a method of training counselors on a brief psychosocial intervention for opioid agonist treatment patients with chronic pain.
24 Apr 2018
News
The open-access model: A promising model for scaling up opioid agonist treatment
Lynn Madden, PhD, MPA, Postdoctoral Associate, and Declan Barry, PhD, Associate Professor of Psychiatry, are the first and senior authors, respectively, of a paper published in Addiction which demonstrates the promise of their "open-access model" for treating patients with opioid use disorder.
12 Apr 2018